Developmental impairment of compound action potential in the optic nerve of myelin mutant taiep rats.
The taiep rat is a myelin mutant with an initial hypomyelination, followed by a progressive demyelination of the CNS. The neurological correlates start with tremor, followed by ataxia, immobility episodes, epilepsy and paralysis. The optic nerve, an easily-isolable central tract fully myelinated by oligodendrocytes, is a suitable preparation to evaluate the developmental impairment of central myelin. We examined the ontogenic development of optic nerve compound action potentials (CAP) throughout the first 6 months of life of control and taiep rats. Control optic nerves (ON) develop CAPs characterized by three waves. Along the first month, the CAPs of taiep rats showed a delayed maturation, with lower amplitudes and longer latencies than controls; at P30, the conduction velocity has only a third of the normal value. Later, as demyelination proceeds, the conduction velocity of taiep ONs begins to decrease and CAPs undergo a gradual temporal dispersion. CAPs of control and taiep showed differences in their pharmacological sensitivity to TEA and 4-AP, two voltage dependent K+ channel-blockers. As compared with TEA, 4-AP induced a significant increase of the amplitudes and a remarkable broadening of CAPs. After P20, unlike controls, the greater sensitivity to 4-AP exhibited by taiep ONs correlates with the detachment and retraction of paranodal loops suggesting that potassium conductances could regulate the excitability as demyelination of CNS axons progresses. It is concluded that the taiep rat, a long-lived mutant, provides a useful model to study the consequences of partial demyelination and the mechanisms by which glial cells regulate the molecular organization and excitability of axonal membranes during development and disease.
Roncagliolo
Manuel
M
Departamento de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Casilla 5030, Valparaíso, Chile. manuel.roncagliolo@uv.cl
Schlageter
Carol
C
León
Claudia
C
Couve
Eduardo
E
Bonansco
Christian
C
Eguibar
José R
JR
D000200:Action Potentials / Q000502:physiology*; D000818:Animals; D002493:Central Nervous System Diseases / Q000503:physiopathology*; D066298:In Vitro Techniques; D009186:Myelin Sheath / Q000235:genetics* / Q000648:ultrastructure; D009900:Optic Nerve / Q000503:physiopathology* / Q000648:ultrastructure; D051381:Rats; D011922:Rats, Mutant Strains; D017207:Rats, Sprague-Dawley